TXMD - TherapeuticsMD Inc
2.3
0 0%
Share volume: 36,274
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.30
0.00
0.00%
Summary score
42%
Profitability
25%
Dept financing
28%
Liquidity
75%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Sep-2013 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-17%
Return on assets
-15.37%
Return on sales
-460.31%
Return on invested capital
207.08%
Total debt ratio
9.78%
Debt ratio change over timeo
0%
Current Ratio
10.53%
Quick Ratio
10.44%
Cash Position Ratio
9.91%
Short-term ratios 30-Sep-2016 - 30-Sep-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-16.98%
Return on assets
-15.25%
Return on sales
-461.9%
Return on invested capital
194.71%
Total debt ratio
10.26%
Debt ratio change over timeo
0%
Current Ratio
10.03%
Quick Ratio
9.94%
Cash Position Ratio
9.43%
Last quarter ratios 30-Sep-2017
The data are presented for the financials results of the last quarter.
Return on equity
-9.81%
Return on assets
-9.25%
Return on sales
-335.75%
Return on invested capital
195.63%
Total debt ratio
6.78%
Debt ratio change over time
0%
Current Ratio
14.43%
Quick Ratio
14.31%
Cash Position Ratio
13.63%
Performance ratios (change over 4 years) 30-Sep-2013 - 30-Sep-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TXMD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -17% | 4.12% | 5.6% | 28.84% |
| Return on assets | -15.37% | 2.87% | 3.58% | 3.88% |
| Return on sales | -460.31% | 20.56% | 28.52% | 38.24% |
| Return on invested capital | 207.08% | 4.34% | 6.5% | 4.27% |
| Profitability | 25% | 36% | 47% | 76% |
| Total debt ratio | 9.78% | 63.22% | 51.03% | 91.42% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 17% | 14% | 25% |
| Current Ratio | 10.03% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 9.94% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 9.43% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 7% | 11% | 9% |
| Short-term ratios | TXMD | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -16.98% | 3.9% | 5.53% | 29.97% |
| Return on assets | -15.25% | 2.93% | 3.51% | 3.83% |
| Return on sales | -461.9% | 20.94% | 28.11% | 37.61% |
| Return on invested capital | 194.71% | 4.21% | 6.14% | 4.25% |
| Profitability | 25% | 37% | 47% | 76% |
| Total debt ratio | 10.26% | 64.39% | 51.75% | 91.67% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 28% | 18% | 14% | 25% |
| Current Ratio | 10.03% | 1.35% | 1.91% | 1.56% |
| Quick Ratio | 9.94% | 0.99% | 1.59% | 1.42% |
| Cash Position Ratio | 9.43% | 0.31% | 0.62% | 0.55% |
| Liquididy | 75% | 7% | 10% | 9% |